These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26936407)

  • 1. A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer.
    Zhou JY; Xu B; Li L
    Drug Dev Res; 2015 Sep; 76(6):263-9. PubMed ID: 26936407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
    Guppy A; Jamal-Hanjani M; Pickering L
    Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
    Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
    Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MicroRNA networks in tissue-specific direct and indirect effects of metformin and its application.
    Yang Q; Wang G; Fang D; Gao X; Liang Y; Wang L; Wu J; Zeng M; Luo M
    Biomed Pharmacother; 2022 Jul; 151():113130. PubMed ID: 35598373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What every dentist should know about metformin, diabetes, and cancer.
    Frykenberg MR; Schneider A; Bashirelahi N
    Gen Dent; 2015; 63(5):70-2. PubMed ID: 26325646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs.
    Alimoradi N; Firouzabadi N; Fatehi R
    Biomed Pharmacother; 2021 Jul; 139():111662. PubMed ID: 34243629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Boolean Logic Modeling of Gene Regulatory Networks to Exploit the Links Between Cancer and Metabolism for Therapeutic Purposes.
    Arshad OA; Venkatasubramani PS; Datta A; Venkatraj J
    IEEE J Biomed Health Inform; 2016 Jan; 20(1):399-407. PubMed ID: 25389247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin, an old drug, brings a new era to cancer therapy.
    He H; Ke R; Lin H; Ying Y; Liu D; Luo Z
    Cancer J; 2015; 21(2):70-4. PubMed ID: 25815846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.
    Ortega FJ; Mercader JM; Moreno-Navarrete JM; Rovira O; Guerra E; Esteve E; Xifra G; Martínez C; Ricart W; Rieusset J; Rome S; Karczewska-Kupczewska M; Straczkowski M; Fernández-Real JM
    Diabetes Care; 2014; 37(5):1375-83. PubMed ID: 24478399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment.
    Sui X; Xu Y; Wang X; Han W; Pan H; Xiao M
    Mol Pharm; 2015 Nov; 12(11):3783-91. PubMed ID: 26430787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: an old drug with new potential.
    Hajjar J; Habra MA; Naing A
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1511-7. PubMed ID: 23978196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin as an Anticancer Agent.
    Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
    Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.
    Wei J; Xie L; Taron M; Rosell R; Liu B
    Drug News Perspect; 2010 Dec; 23(10):655-61. PubMed ID: 21180651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repositioning metformin for cancer prevention and treatment.
    Quinn BJ; Kitagawa H; Memmott RM; Gills JJ; Dennis PA
    Trends Endocrinol Metab; 2013 Sep; 24(9):469-80. PubMed ID: 23773243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New perspectives for metformin in cancer therapy].
    Loubière C; Dirat B; Tanti JF; Bost F
    Ann Endocrinol (Paris); 2013 May; 74(2):130-6. PubMed ID: 23587351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.
    Gong J; Kelekar G; Shen J; Shen J; Kaur S; Mita M
    Target Oncol; 2016 Aug; 11(4):447-67. PubMed ID: 26864078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients.
    Steffensen LB; Feddersen S; Preil SR; Rasmussen LM
    Cardiovasc Diabetol; 2018 May; 17(1):72. PubMed ID: 29773082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.